Filing Details

Accession Number:
0001140361-16-054824
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-25 14:27:52
Reporting Period:
2016-02-17
Filing Date:
2016-02-25
Accepted Time:
2016-02-25 14:27:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1094176 Anne M Szostak One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-17 2,000 $69.94 8,816 No 4 P Indirect M. Anne Szostak Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect M. Anne Szostak Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 584 Direct
Common Stock 6,600 Indirect 2014 Szostak IDEXX GRAT
Footnotes
  1. The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $69.890 to $69.980, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.